NANOVIRICIDES, INC. Amortization of Intangible Assets
NANOVIRICIDES, INC. (NNVC) reported Amortization of Intangible Assets of $2.07 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-05-15
- NANOVIRICIDES, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $2.07K, a 0.00% change year-over-year.
- NANOVIRICIDES, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $2.07K, a 0.05% increase year-over-year.
- NANOVIRICIDES, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $2.07K, a 0.05% increase year-over-year.
- NANOVIRICIDES, INC. amortization of intangible assets for the quarter ending 2025-06-30 was $2.07K, a 0.05% decline year-over-year.
- NANOVIRICIDES, INC. amortization of intangible assets for fiscal 2025 was $8.27K, a 0.01% decline from fiscal 2024.
- NANOVIRICIDES, INC. amortization of intangible assets for fiscal 2024 was $8.27K, a 0.00% change from fiscal 2023.
- NANOVIRICIDES, INC. amortization of intangible assets for fiscal 2023 was $8.27K, a 0.00% change from fiscal 2022.
- NANOVIRICIDES, INC. amortization of intangible assets for fiscal 2022 was $8.27K, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $2.07K 10-Q · filed 2026-05-15 | $4.13K derived: sum of 2 quarters · filed 2026-05-15 | $6.20K 10-Q · filed 2026-05-15 | $8.27K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | $2.07K 10-Q · filed 2026-02-17 | $4.13K 10-Q · filed 2026-02-17 | $6.20K derived: sum of 3 quarters · filed 2026-02-17 | $8.27K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-09-30 | $2.07K 10-Q · filed 2025-11-14 | $4.13K derived: sum of 2 quarters · filed 2025-11-14 | $6.20K derived: sum of 3 quarters · filed 2026-05-15 | $8.27K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $4.13K derived: sum of 2 quarters · filed 2026-05-15 | $6.20K derived: sum of 3 quarters · filed 2026-05-15 | $8.27K 10-K · filed 2025-09-29 | |
| 2025-03-31 | $2.07K 10-Q · filed 2026-05-15 | $2.07K 10-Q · filed 2025-05-15 | $4.13K derived: sum of 2 quarters · filed 2026-05-15 | $6.20K 10-Q · filed 2026-05-15 | $8.27K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $2.07K 10-Q · filed 2026-02-17 | $4.13K 10-Q · filed 2026-02-17 | $6.20K derived: sum of 3 quarters · filed 2026-02-17 | $8.27K derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | $2.07K 10-Q · filed 2025-11-14 | $4.13K derived: sum of 2 quarters · filed 2025-11-14 | $6.20K derived: sum of 3 quarters · filed 2025-11-14 | $8.27K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $4.13K derived: sum of 2 quarters · filed 2025-09-29 | $6.20K derived: sum of 3 quarters · filed 2025-09-29 | $8.27K 10-K · filed 2025-09-29 | |
| 2024-03-31 | $2.07K 10-Q · filed 2025-05-15 | $4.13K derived: sum of 2 quarters · filed 2025-05-15 | $6.20K 10-Q · filed 2025-05-15 | $8.27K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | $4.13K 10-Q · filed 2025-02-14 | $6.20K derived: sum of 3 quarters · filed 2025-02-14 | $8.27K derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | $2.07K 10-Q · filed 2024-11-14 | $4.13K derived: sum of 2 quarters · filed 2024-11-14 | $6.20K derived: sum of 3 quarters · filed 2024-11-14 | $8.27K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $4.13K derived: sum of 2 quarters · filed 2024-09-27 | $6.20K derived: sum of 3 quarters · filed 2024-09-27 | $8.27K 10-K · filed 2024-09-27 | |
| 2023-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $4.13K derived: sum of 2 quarters · filed 2024-05-15 | $6.20K 10-Q · filed 2024-05-15 | $8.27K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $4.13K 10-Q · filed 2024-02-14 | $6.20K derived: sum of 3 quarters · filed 2024-02-14 | $8.27K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $2.07K 10-Q · filed 2023-11-14 | $4.13K derived: sum of 2 quarters · filed 2023-11-14 | $6.20K derived: sum of 3 quarters · filed 2023-11-14 | $8.27K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | $4.13K derived: sum of 2 quarters · filed 2023-10-13 | $6.20K derived: sum of 3 quarters · filed 2023-10-13 | $8.27K 10-K · filed 2023-10-13 | |
| 2022-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $4.13K derived: sum of 2 quarters · filed 2023-05-15 | $6.20K 10-Q · filed 2023-05-15 | $8.27K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $4.13K 10-Q · filed 2023-02-14 | $6.20K derived: sum of 3 quarters · filed 2023-02-14 | $8.27K derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | $2.07K 10-Q · filed 2022-11-14 | $4.13K derived: sum of 2 quarters · filed 2022-11-14 | $6.20K derived: sum of 3 quarters · filed 2022-11-14 | $8.27K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-13 | $4.13K derived: sum of 2 quarters · filed 2022-10-13 | $6.20K derived: sum of 3 quarters · filed 2022-10-13 | $8.27K 10-K · filed 2022-10-13 | |
| 2021-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $4.13K derived: sum of 2 quarters · filed 2022-05-16 | $6.20K 10-Q · filed 2022-05-16 | $8.27K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $4.13K 10-Q · filed 2022-02-14 | $6.20K derived: sum of 3 quarters · filed 2022-02-14 | $8.27K derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | $2.07K 10-Q · filed 2021-11-15 | $4.13K derived: sum of 2 quarters · filed 2021-11-15 | $6.20K derived: sum of 3 quarters · filed 2021-11-15 | $8.27K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $4.13K derived: sum of 2 quarters · filed 2021-10-12 | $6.20K derived: sum of 3 quarters · filed 2021-10-12 | $8.27K 10-K · filed 2021-10-12 | |
| 2020-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $4.14K derived: sum of 2 quarters · filed 2021-05-14 | $6.20K 10-Q · filed 2021-05-14 | $8.27K derived: sum of 4 quarters · filed 2021-10-12 | |
| 2019-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $4.13K 10-Q · filed 2021-02-16 | $6.20K derived: sum of 3 quarters · filed 2021-10-12 | $8.27K derived: sum of 4 quarters · filed 2021-10-12 | |
| 2019-09-30 | $2.07K 10-Q · filed 2020-11-16 | $4.13K derived: sum of 2 quarters · filed 2021-10-12 | $6.20K derived: sum of 3 quarters · filed 2021-10-12 | $8.27K derived: sum of 4 quarters · filed 2021-10-12 | |
| 2019-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $4.13K derived: sum of 2 quarters · filed 2021-10-12 | $6.20K derived: sum of 3 quarters · filed 2021-10-12 | $8.27K 10-K · filed 2021-10-12 | |
| 2019-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-22 | $4.13K derived: sum of 2 quarters · filed 2020-06-22 | $6.20K 10-Q · filed 2020-06-22 | ||
| 2018-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $4.14K 10-Q · filed 2020-02-14 | |||
| 2018-09-30 | $2.07K 10-Q · filed 2019-11-15 | ||||
| 2018-06-30 | $8.27K 10-K · filed 2020-10-13 | ||||
| 2017-06-30 | $8.27K 10-K · filed 2019-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |